Metro Atlanta Chamber Bioscience Leadership Council Asks ‘What’s Next?’
Photo: “Guest speaker at the June meeting of the Bioscience Leadership Council – Patientory Founder and CEO Chrissa McFarlane – addresses the attendees.”
This article is part of a continuing series of posts on the Metro Atlanta Chamber’s council groups. Learn more about the Chamber’s work by exploring these leadership councils and the impact they have on the metro region. The previous entry covered MAC’s Supply Chain Leadership Council and the industry’s digital transformation.
Chaired by industry trailblazers from Morehouse School of Medicine, athenahealth and Spencer Stuart, the Metro Atlanta Chamber’s Bioscience Leadership Council brings together the most advanced research programs, world-class universities and both public and private organizations. With partners across the region and businesses from FORTUNE 500 companies to startups, the council provides a platform to present breakthrough technologies, address skill gaps, market our region and create awareness specific to industry expansion opportunities.
The second quarter meeting included What’s New, What’s Next & What’s Needed for the bioscience industry. The discussion highlighted new innovations in digital health, hospitals, vaccines and healthcare delivery. Next, Patientory Founder and CEO Chrissa McFarlane shared her challenges and triumphs navigating the innovation ecosystem, including how her company recently raised $7.2 million in just three days to expand their blockchain technology.
Todd Haedrich, vice president and general manager of small groups at athenahealth, closed the meeting by highlighting advancing technologies in artificial intelligence, blockchain, cloud storage and wearables. The major discussion point involved what it will mean to move these technologies into consumers’ homes and how Atlanta can make an impact addressing global needs.
“Readmission, immune response, patient satisfaction and data storage are a few of the technologies Atlanta will continue to move the needle on. The Metro Atlanta Chamber will continue to bring together thought leaders who will leverage the advantages and assets in our region and truly make a global impact,” said Kornelius Bankston, MAC’s director of bioscience ecosystem expansion.
Recognized as the center of global health and health IT capital of the U.S., metro Atlanta is a powerhouse for the rapidly growing bioscience industry. With more than 200 life science companies employing more than 30,000 people, the state’s bioscience industry is anchored by world-class organizations like the Centers for Disease Control and Prevention, American Cancer Society, Arthritis Foundation, CARE, The Carter Center, Task Force for Global Health and many more.
The next Bioscience Leadership Council meeting will be held September 12 at the Metro Atlanta Chamber.
If you have any questions on how your organization can engage with MAC, please contact Jack Murphy.